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FOXO3a gene polymorphism and bronchial asthma in Egyptian children 
 
INTRODUCTION 
Bronchial asthma is the most prevalent chronic 
immunological disorder in childhood period. It is 
characterized by airways inflammation and 
bronchial hyper-responsiveness where complex 
gene-environment interactions play a significant 
role in its pathogenesis. 1,2 Asthma is a disorder 
whose primary cause can probably be linked to the 
disturbed immunoregulatory mechanisms at the 
lymphocyte level.3 Inflammation in asthma occurs 
due to excessive infiltration of cells predominantly 
T lymphocytes, eosinophils, neutrophils, 
macrophages and mast cells along with elevated 
levels of cytokines and tumor necrosis factor-α.4  
FOX (Forkhead box) proteins are a family of 
transcription factors that bind condensed chromatin 
during cell differentiation and play important roles 
in regulating the expression of genes involved in 
cell growth, proliferation, differentiation, and 
longevity.5   FOXO3 is a member of the forkhead 
box class O (FOXO) subfamily6. The role of FOXO 
family members in inflammation is a complex role 
involving wide range of target cells and genes.  
FOXO3 inhibits T cell proliferation, induces T 
cell apoptosis via upregulation of proapoptotic 
proteins such as Puma and Bim and it suppresses T 
cell activation preventing autoimmunity.7 
Moreover, FOXO3 inhibits the capacity of dendritic 
cells to produce IL-6  so it can control the 
magnitude of T cell in immune responses.8 FOXO3 
also promotes B cell apoptosis via upregulation of 
proapoptotic genes and antiproliferative genes.9 
Mice studies revealed that FOXO3a deficiency 
leads to T cell hyper activation, inflammation, 
increased activity of proinflammatory genes; IL2 
and IFN-γ and increased activity of pro-
inflammatory transcription factor NF-κB.10 
Moreover, inhibiting FOXO3a gene leads to 
promotion of autoaggressive T cells in mouse 
model of multiple sclerosis.11  
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FOXO3 also regulates Treg cells generation 
through affecting FOXp3 expression.12 Treg cells 
are responsible for keeping proper immunological 
tolerance.13  Loss of FOXP3 expression may lead to 
maintaining a state of chronic inflammation through 
loss of Treg cell functions and or numbers.14   
Moreover, FOXO3a initiates TGF-1 dependent 
pathway in monocytes through which it reduces 
proinflammatory cytokines and promotes the anti-
inflammatory cytokines production.15 
FOXO3a alteration has been implicated in the 
pathogenesis of different disease conditions such as 
idiopathic pulmonary fibrosis, lung cancer and 
bronchiolitis.16-18   Few studies were conducted on 
bronchial asthma in different ethnic groups. 
However, studies in our Egyptian population are 
still lacking.  Recently, a significant association 
between the FOXO3a single-nucleotide 
polymorphism (rs13217795) and susceptibility to 
asthma and was described by Barkund  et al. (2015) 
and Amarin et al. (2017).19,20 Furthermore, the study 
by Barkund  et al. (2015) revealed that FOXO3a 
SNP (rs13217795) is significantly associated with 
asthmatics plausibly contributing to the 
hyperactivity of T cells, neutrophils, and mast cells, 
increased production of proinflammatory cytokines, 
and downregulation of anti-inflammatory 
cytokines19.  
Therefore, the current study aimed to detect if 
there is an association between single nucleotide 
polymorphism (rs13217795) of the FOXO3a gene 
and bronchial asthma, atopy and asthma severity 
among Egyptian children.   
 
METHODS 
Study design and subjects 
The present cross-sectional case-control study was 
conducted at the University Children’s Hospital, 
Faculty of Medicine, Cairo University on 75 
asthmatic patients following up at the allergy and 
pulmonology outpatient clinic. Patient diagnosis 
and assessment of severity classification (mild, 
moderate and severe persistent) were done 
according to GINA guidelines for asthma.1  
Patients’ age ranged from 2 to 12 years. Seventy-
five age and sex matched healthy children with no 
history or symptoms of bronchial asthma, 
pulmonary diseases, allergy, or atopic dermatitis 
and no first – degree relative suffering from 
bronchial asthma or atopic dermatitis were included 
as controls. Patients were excluded if having other 
causes of wheezy chest: bronchiolitis obliterans, 
cystic fibrosis, autoimmune disorders, 
immunocompromised patients or patients with 
gastro-esophageal reflux disease. 
All patients were subjected to a complete 
clinical study (thorough history and physical 
examination) upon study inclusion, with emphasis 
on chest symptoms, other atopic manifestations and 
severity of disease. FOXO3a gene polymorphism 
using PCR-RFLP technique was performed for all 
patients and controls. 
 
Detection of FOXO3a Polymorphism using PCR-
RFLP 
Genomic DNA of included subjects was isolated 
from venous blood collected on ethylene diamine 
tetra-acetic acid vacutainer tubes using G-spinTM 
total DNA extraction kit (iNtRON biotechnology, 
Korea). Genotyping of FOXO3a polymorphism was 
performed using PCR-RFLP technique. The primer 
sequences used were as follows: Forward Primer 5′-
CTC CTT GGT CAG TTT GGT G 3′; Reverse 
Primer: 5′-ATG AGT GAA GAT GGA AGT AAG 
C -3′19.  Amplification was performed using   2X 
PCR master mix solution (iTaqTM) (iNtRON 
biotechnology, Korea) in total volume of 20μl. For 
PCR amplification, an initial denaturation at 95oC 
for 5 min was followed by 35 cycles consisting of 
30 sec of denaturation at 95 °C, 30 sec of annealing 
at 62 °C and extension for 1 min at 72 °C and then a 
final extension at 72 °C for 5 min. Amplification 
products were subjected to restriction digestion by 
the enzyme PagI (Thermoscientific, USA). 
Fragments were separated on 2% agarose gel and 
bands were visualized by ethidium bromide staining 
under ultraviolet light. This reaction yielded one 
fragment of 667 bp indicating a homozygous wild 
genotype (CC), or two fragments of 391 and 275 bp 
indicating a homozygous mutant genotype (TT) 
while the presence of 677,391 and 275 bp products 
indicated heterozygous genotype (CT), Figure (1).
  
Ethical considerations 
The aim and nature of the study was explained for 
each parent before inclusion. An informed written 
consent was obtained from parents / surrogates 
before enrollment. The ethical committee of the 
Pediatrics department, Faculty of Medicine, Cairo 
University approved the work and it conforms to 
the provisions of the Declaration of Helsinki in 




Sample size calculation was performed using Power 
and Sample Size Calculator program version 3.0.43. 
It was based on the following inputs: Power of 
80%, type I error of 0.05, equal number of 
candidates in both cases and controls, true 
FOXO3a gene in Egyptian asthmatic children 
33 
 
difference in means between groups of 0.12 and 
standard deviation of 0.26. It was found to be 73 
children in each group (total = 146). 
 
Statistical analysis 
Data were statistically described in terms of mean  
standard deviation ( SD), median and range, or 
frequencies and percentages when appropriate. 
Comparison of numerical variables between the 
study groups was done using Kruskal Wallis test. 
For comparing categorical data, Chi-square (2) 
test was performed. Exact test was used instead 
when the expected frequency is less than 5. Odds 
ratio (OR) and its 95% confidence interval (95% 
CI) was calculated for genotypic frequencies 
between cases and controls. P values less than 0.05 
were considered statistically significant. All 
statistical calculations were done using computer 
program IBM SPSS (Statistical Package for the 
Social Science; IBM Corp, Armonk, NY, USA) 




The study included 75 asthmatic children; 37 
(49.3%) experienced mild asthma, 17 (22.7%) had 
moderate asthma and 21 (28%) showed severe 
persistent asthma. Patient diagnosis and assessment 
of severity classification were done according to 
GINA guidelines for asthma.1 Patients were aged 2-
12 years with a mean age of 6.3 ±1.9 years. Forty-
two (56 %) were males and 33 (44 %) were 
females. A positive family history of allergic 
disease as conjunctivitis, allergic rhinitis, skin 
allergy or bronchial asthma was present in 93.3%. 
Atopic manifestations were found in 55 cases 
(73%). Seventy-five age and sex matched healthy 
children with no previous history of atopic 
disorders were include as controls. Table (1) shows 
the basic demographic data of asthmatic patients.  
 
FOXO3a gene polymorphism  
Genotypic distribution and allele frequencies of the 
FOXO3a gene polymorphism did not show 
statistically significant differences between cases 
and controls as shown in Table (2). Generally, CT 
genotype represented the most frequent genotype in 
cases and controls (50.7% and 61.4% respectively) 
followed by CC genotype (37.3% and 22.7% 
respectively) and then TT genotype (12% and 16% 
respectively).C allele was more prevalent in both 
cases and controls (62.8% and 53.3% respectively) 
while the T allele was detected in 37.3% of cases 
and 46.7% of the control group. 
Asthmatic patients were subdivided into 3 
groups according to disease severity; mild, 
moderate and severe persistent asthma. Genotypic 
distribution and allele frequencies did not show a 
significant difference between mild, moderate and 
severe persistent cases (p-value = 0.545, p-value 
0.961 respectively) (Table 3). CT genotype was the 
most frequent genotype in the 3 groups (60%, 47% 
and 48% respectively). Regarding allelic 
frequencies, the C allele was the most prevalent in 
the 3 groups (62%, 65% and 62% respectively). 
Comparison between asthmatic patients having 
atopic manifestations (73%) and those without 
atopic manifestations (27%) revealed no 
statistically significant difference regarding the 
genotypic distribution (p-value= 0.536) or the 
allelic frequencies (p-value= 0.722) as 
demonstrated in Table (4). 
 
 
Figure 1. PCR-RFLP products of FOXO3A gene 
polymorphism. 
Lanes 1, 5 and 7 represent RFLP pattern for homozygous 
mutant (TT). Lanes 2, 3 and 6 represent RFLP pattern for 
heterozygous (CT). Lane 4 represents RFLP pattern for 
homozygous wild type (CC). Lane 8 consists of the 100 bp 
DNA marker. 
 
Table 1. Basic demographic data of asthmatic patients 
 
















Family history for allergic conditions 
Asthma severity 
• Mild persistent 
• Moderate persistent 
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CT genotype 38 (50.7%) 46 (61.3%)    
TT genotype 9 (12%) 12 (16%) 







1.080 T allele 56 (37.2%) 70 (46.7%) 




Table 3. Relation between genotypic distribution and allelic frequencies of FOXO3 gene polymorphism and 
different grades of asthma severity. 
 
















CT genotype 22 (60%) 8 (47%) 
TT genotype 3 (8%) 2 (12%) 
C allele 46 (62%) 22 (65%) 26 (62%)  0.961 
T allele 28 (38%) 12 (35%) 16 (38%) 
aP value less than 0.05 is statistically significant 
            
 












CC genotype 19 (34%) 9 (45%)  
0.536 CT genotype 30 (55%) 8 (40%) 
TT genotype 6 (11%) 3 (15%) 
C allele 68 (61%) 26 (65%)  
0.722 T allele 42 (39%) 14 (35%) 
aP value less than 0.05 is statistically significant 
       
DISCUSSION 
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Genetics play a significant role in the development 
of asthma and allergy as demonstrated in family 
and twin studies21. Genetic researches; genome-
wide linkage studies and case–control studies, have 
identified several genomic regions and more than 
100 genes associated with allergy and asthma in 
different populations22.  
FOXO transcriptional factors exert crucial roles 
in immunoregulation as FOXO members are 
predominately expressed in the peripheral lymphoid 
organs. FOXO3a deficiency has been associated 
with spontaneous lymphoid proliferation, 
inflammation in different organs and increased 
hyperactivated T helper cells.10  
The association between FOXO3a 
polymorphisms and different types of inflammatory 
diseases as idiopathic pulmonary fibrosis, lung 
cancer, bronchiolitis, Crohn’s disease, rheumatoid 
arthritis and Sjogren’s syndrome has been 
demonstrated in previous studies.16-18,23,24  To our 
knowledge, the association between FOXO3a gene 
polymorphism and asthma has only been explored 
in two previous studies19, 20.  Herein, we focused on 
exploring the association between FOXO3a gene 
polymorphism and asthma, atopy and asthma 
severity in Egyptian population. 
In this study, the CT, CC and TT genotypes of 
the FOXO3a gene polymorphism didn’t show any 
statistically significant difference in distribution 
between asthmatic patients and controls. Generally, 
CT genotype represented the highest prevalent 
genotype in both patients and controls while the TT 
genotype was the least. On the other hand, Barkund  
et al. (2015) determined that in their asthmatic 
patients, the TT mutant genotype had the highest 
frequency (51.75%) and the T mutant allele showed 
the highest prevalence (71%).19 Similar results were 
shown by Amarin et al. (2017) where the frequency 
of mutant TT genotype was the highest (49%) and 
the mutant T allele was present in 64% of 
asthmatics.20 
Regarding the controls, a previous study showed 
a near similar frequency compared to our study, 
with the heterozygous CT genotype showing the 
highest frequency (57 %) and the TT genotype  the 
lowest (22 %) with the C and T allele frequencies 
were nearly the same (49% and 51% 
respectively).20 Similarly, another  study stated that 
the CC genotype represented the highest prevalence 
(50.7%) in controls while the TT genotype had the 
least (12.7%) and the C allele was more prevalent 
(69%) than the mutant T allele.19 The similarities in 
the frequency of the gene distribution in controls in 
our study and the previous two studies in addition 
to the discrepancy in the distribution in asthmatic 
patients especially for the mutant TT genotype 
suggests that there may be no association between 
FOXO3a gene polymorphism and asthma in the 
Egyptian population. Genotypic distribution and 
allele frequencies of FOXO3a gene polymorphism 
did not show a significant difference between 
different grades of asthma severity; mild, moderate 
and sever persistent groups (p-value= 0.545, p-
value= 0.961 respectively). Furthermore, asthmatic 
patients having atopic manifestations did not differ 
significantly from those without atopic 
manifestations as regards the genotypic distribution 
(p-value= 0.536) or the allelic frequencies of 
FOXO3a polymorphism (p-value= 0.722). To date, 
no studies are available addressing the association 
between the FOXO3a gene polymorphism and 
atopy or asthma severity.   
FOX family members’ role in inflammation is 
highly cell and context specific. As some of FOX 
family transcription factors maintain the naïve T 
cells and prevent autoimmunity. As a result, loss of 
activity of one of these factors may lead to chronic 
inflammation. On the other hand, some of the FOX 
family members promote chronic inflammation by 
maintaining survival of inflammatory cells such as 
neutrophils.14 Chronic inflammation pathogenesis is 
a complex process of interactions between different 
inflammatory cells, transcriptional factors and 
inflammatory genes. Moreover, FOXO3a activity is 
regulated through posttranslational modification; 
acetylation, phosphorylation, and ubiquitination 
which may affect the protein level after 
transcription.25   
In conclusion, comparison of our results with 
other studies indicates that FOXO3a gene 
polymorphism is not universally associated with 
asthma, atopy or disease severity. The genetic basis 
of asthma may differ between different ethnic 
groups. Future large-scale studies should be 
conducted focusing on the presence or absence of a 
role of the FOXO3a gene polymorphism and 
estimation of FOXO3a protein level in relation to 
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